| |
 |
|
Class Information
Number: 514/327
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > Hetero ring is six-membered consisting of one nitrogen and five carbon atoms > Piperidines > Additional ring containing > Chalcogen bonded directly to ring carbon of the piperidine ring
Description: Subject matter wherein chalcogen (i.e., oxygen, sulfur, selenium or tellurium) is bonded directly to a ring carbon of the piperidine ring.
Sub-classes under this class:
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 6458806 |
Aryl alkenamides derivatives as MCP-1 antagonists |
Oct. 1, 2002 |
| 6455549 |
Arylpiperidinol and arylpiperidine derivatives and drugs containing the same |
Sep. 24, 2002 |
| 6455531 |
Hydroxamic acid derivatives |
Sep. 24, 2002 |
| 6444686 |
N-ureidoalkyl-piperidines as modulators of chemokine receptor activity |
Sep. 3, 2002 |
| 6440999 |
Intimal thickening inhibitory agent |
Aug. 27, 2002 |
| 6436938 |
Combination treatment for depression |
Aug. 20, 2002 |
| 6420427 |
Aminobutyric acid derivatives |
Jul. 16, 2002 |
| 6403584 |
Substituted nipecotyl derivatives as inhibitors of cell adhesion |
Jun. 11, 2002 |
| 6403592 |
Aralkyl and aralkylidene heterocyclic lactams and imides |
Jun. 11, 2002 |
| 6403601 |
N-(2-phenyl-4-piperidinybutyl)-5,6,7,8-tetrahydro-1-naphthalenecarboxamides and their use as neurokinin 1 (NK1) and/or neurokinin 2 (NK2) receptor antagonists |
Jun. 11, 2002 |
| 6403612 |
Thrombin receptor antagonists |
Jun. 11, 2002 |
| 6395753 |
Cyclic amine compounds and pharmaceutical composition containing the same |
May. 28, 2002 |
| 6395757 |
Method for treating hot flashes in humans |
May. 28, 2002 |
| 6384052 |
Anticoccidial compounds |
May. 7, 2002 |
| 6369079 |
Methods for treating irritable bowel syndrome using optically pure (+) norcisapride |
Apr. 9, 2002 |
| 6365603 |
Aromatic compounds and pharmaceutical compositions containing them |
Apr. 2, 2002 |
| 6362202 |
Methods and compositions using (-) norcisapride in combination with proton pump inhibitors or H2 receptor antagonists |
Mar. 26, 2002 |
| 6362203 |
4-hydroxy-4-phenylpiperidine derivatives and pharmaceuticals containing the same |
Mar. 26, 2002 |
| 6358982 |
Heterocyclyl sulphonamide derivatives |
Mar. 19, 2002 |
| 6355657 |
System for percutaneous delivery of opioid analgesics |
Mar. 12, 2002 |
| 6353004 |
Peripherally acting anti-pruritic opiates |
Mar. 5, 2002 |
| 6353005 |
Method and compositions using (+) norcisapride in combination with proton pump inhibitors or H2 receptor antagonist |
Mar. 5, 2002 |
| 6350761 |
Benzenamine derivatives as anti-coagulants |
Feb. 26, 2002 |
| 6340691 |
Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase and tace inhibitors |
Jan. 22, 2002 |
| 6339096 |
Urethanes derived from azacycloalkanes, the thio and dithio analogues thereof and their use as cholesterol biosynthesis inhibitors |
Jan. 15, 2002 |
| 6326372 |
Lactam and cyclic urea derivatives useful as alpha 1a adrenoceptor antagonists |
Dec. 4, 2001 |
| 6323038 |
Diagnostic reagent for complications associated with diabetes or renal failure |
Nov. 27, 2001 |
| 6323222 |
1-aza-2-alkyl-6-aryl-cycloalkane compounds |
Nov. 27, 2001 |
| 6319937 |
Isoxazoline fibrinogen receptor antagonists |
Nov. 20, 2001 |
| 6316269 |
Methods for screening drugs to predict tardive dyskinesia |
Nov. 13, 2001 |
| 6313119 |
Sulfonamide derivatives as inhibitors of bone resorption and as inhibitors of cell adhesion |
Nov. 6, 2001 |
| 6313122 |
Antithrombotic agents |
Nov. 6, 2001 |
| 6313144 |
Compositions of optically pure (-) norcisapride |
Nov. 6, 2001 |
| 6306882 |
Reagents for assaying central local acetylcholinesterase activity |
Oct. 23, 2001 |
| 6306881 |
Anti-inflammatory agents |
Oct. 23, 2001 |
| 6303593 |
3-thienyl and 3-furanyl pyrrolidine modulators of chemokine receptor activity |
Oct. 16, 2001 |
| 6297260 |
Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use |
Oct. 2, 2001 |
| 6297259 |
Substituted N-methyl-N-(4-(piperidin-1-yl)-2-(aryl)butyl) benzamides useful for the treatment of allergic diseases |
Oct. 2, 2001 |
| 6294537 |
Compounds which are specific antagonists of the human NK3 receptor and their use as medicinal products and diagnostic tools |
Sep. 25, 2001 |
| 6291516 |
Regulators of the hedgehog pathway, compositions and uses related thereto |
Sep. 18, 2001 |
| 6288071 |
1-ethylene-2-alkylene-1,4-cyclohexadiene pesticides |
Sep. 11, 2001 |
| 6288086 |
N-hydroxy-2-(alkyl, aryl, or heteroaryl, sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
Sep. 11, 2001 |
| 6274584 |
Compounds with growth hormone releasing properties |
Aug. 14, 2001 |
| 6258827 |
Combinations for the treatment of parkinsonism containing selective NMDA antagonists |
Jul. 10, 2001 |
| 6242465 |
Compositions of optically pure (+) norcisapride |
Jun. 5, 2001 |
| 6235778 |
Aminoguanidines and alkoxyguanidines as protease inhibitors |
May. 22, 2001 |
| 6221878 |
Method for treatment of depression |
Apr. 24, 2001 |
| 6197791 |
N-hdroxy-2-(alkyl, aryl, or heteroaryl, sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
Mar. 6, 2001 |
| 6194435 |
Lactams as selective factor Xa inhibitors |
Feb. 27, 2001 |
| 6191156 |
Compositions and methods for treating bladder dysfunction |
Feb. 20, 2001 |
|
|
|
